TechInvention reveals positive outcomes of its indigenously developed recombinant subunit SARS-CoV-2 vaccine

RCB Facility Where The Product Got Developed

CoviTechTM vaccine may have the potential to address the burning issue of mutations, especially the ‘Variants of Concern’ (VOC) which has been hammering countries through subsequent waves of infection. TechInvention Lifecare Pvt. Ltd., a Biotech start-up company based out of Mumbai, India has revealed positive outcomes of its recombinant subunit SARS-CoV-2 vaccine (CoviTechTM) in a … Read more

J&J Seeks Emergency Approval of COVID Vaccine

Feb. 5, 2021 — The world’s first single-dose COVID-19 vaccine, from Johnson & Johnson, has been submitted to the U.S. Food and Drug Administration for emergency use approval. Preliminary findings from a large international study suggest the vaccine isn’t quite as strong as the two current FDA-approved vaccines from Pfizer and Moderna, which are … Read more